Susquehanna International Group’s EnteroMedics Inc. ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-716
Closed -$7K 10772
2016
Q3
$7K Buy
716
+2
+0.3% +$27 ﹤0.01% 8300
2016
Q2
$15K Hold
714
﹤0.01% 8404
2016
Q1
$48K Buy
+714
New +$57.7K ﹤0.01% 8676
2015
Q3
Sell
-121
Closed -$79K 11052
2015
Q2
$79K Buy
121
+7
+6% +$8.05K ﹤0.01% 9759
2015
Q1
$109K Buy
114
+42
+58% +$50.6K ﹤0.01% 8937
2014
Q4
$108K Sell
72
-31
-30% -$41.9K ﹤0.01% 9163
2014
Q3
$133K Buy
103
+72
+232% +$106K ﹤0.01% 8967
2014
Q2
$50K Sell
31
-10
-24% -$18.7K ﹤0.01% 9590
2014
Q1
$79K Buy
41
+15
+58% +$35.5K ﹤0.01% 8630
2013
Q4
$56K Buy
+26
New +$41.9K ﹤0.01% 8776

Other funds holding ETRM

Susquehanna International Group's ETRM Position: Q4 2016 in Review

Susquehanna International Group sold out of EnteroMedics Inc. (ETRM) in Q4 2016, closing a stake of 680 shares — an estimated $6K sold.

Susquehanna International Group first reported a position in ETRM in Q2 2013 and held it in 12 quarters. The position peaked at $1.34M in Q2 2015. 18 funds tracked by Wall St. Rank hold ETRM as of Q4 2016.

  • Susquehanna International Group reported no remaining EnteroMedics Inc. position as of Q4 2016 after selling out during the quarter.
  • Susquehanna International Group sold 680 EnteroMedics Inc. shares in Q4 2016, an estimated $6K.
  • Susquehanna International Group first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 12 quarters.
  • Susquehanna International Group's EnteroMedics Inc. position peaked at $1.34M in Q2 2015.
  • 18 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.